For Clinicians

Let Us Help
You Help Your Patients

Combination Infusion Therapy for Treatment Resistant Depression, Anxiety, PTSD,  Migraines & Headaches, Chronic Pain and more

How We Work With Clinicians

Patients are best served when the all members of the provider team work together and are fully informed.

We value your expertise and welcome the opportunity to support you and your patients.

Image Name-Referrals for Clinicians

We Work With:

    • Psychiatrists
    • Therapists
    • Psychologists
    • Neurologists
    • Pain Specialists
    • Primary Care Physicians
    • Coaches
    • Social Workers

Our Services:

    • IV Ketamine
    • IV NAD+
    • IV Nutrients & Vitamins
    • Intranasal Ketamine & NAD+
    • IV Glutathione
    • Ketamine Assisted Psychotherapy (KAP)

Treatments for:

    • Depression
    • Anxiety
    • PTSD
    • Migraines & Headaches
    • CRPS & Chronic Pain
    • Immunity & Resilience

We Can Help

Refer Your Patient To Us

If you are a doctor or therapist with a patient you think could benefit from Combination Infusion Therapy, then please submit our referral form.


We work with providers that fall broadly into 3 categories:

Emotional Pain

  • Primary Care Physicians
  • Neurologists
  • Psychiatrists
  • Psychologists
  • Therapists/Counselors
  • Life Coaches
  • Social Workers

Physical Pain

  • Pain Specialists
  • Primary Care Physicians
  • Surgeons
  • Orthopedic Specialists
  • Neurologists
  • Physical Therapists


  • Primary Care Physicians
  • Functional Medicine Providers
  • Dieticians
  • Athletic Coaches
  • Life Coaches

As soon as we receive your patient referral we will reach out to your patient via phone call. The purpose of this call is to confirm their interest in Combination Infusion Therapy and answer any questions they may have. If at the end of the call they would like to proceed they will be asked to submit a New Patient Intake Form. This provides us with the necessary contact information and medical history so we can begin onboarding them. After reviewing their intake information we will reach out to you to discuss your patient’s medical condition and better understand your reason for making the referral to CIT Clinics. If we still agree that these treatments may benefit your patient our team will begin scheduling their first treatment.

We pride ourselves in being very administratively efficient because it means we can intake new patients quickly and easily. Assuming there are no medical contraindications we can usually offer an appointment for new patients within 1 week of processing their intake form and speaking with you as their referring provider. Please begin your referral by submitting a New Patient Referral. If you have any questions about our process please call 415.475.9660. We’re happy to help.

How We Work With You

We pride ourselves on offering our patients a process that is administratively efficient and clinically rigorous while maintining a high level of personalized care and attention. 

Confirm Your Patient's Interest

The first step is to confirm your patient's openness/interest in infusion therapies such as Ketamine, NAD+, Vitamins, Glutathione, etc.

Submit Online Patient Referral Form

We will call your insurance provider to understand your benefits and get an estimate of how much they may reimburse you.

Review Patient Care Plan With Us

Once we have spoken with your patient and received required documents, we will contact you to confirm/discuss our treatment plan. We value your input and experience and will work closely with you to ensure the best patient care possible.

Provide Ongoing Updates About Treatments and Progress

With your patient's consent, we will share treatment information with you in order to keep you informed of their progress.

Latest Science & Research

nejm1-1-Trial of Psilocybin versus Escitalopram for Depression

Trial of Psilocybin versus Escitalopram for Depression

April 15, 2021

Psilocybin may have antidepressant properties, but direct comparisons between psilocybin and established treatments for depression are lacking.

Read More
intranasal-Comparative Efficacy of Racemic Ketamine and Esketamine for Depression

Comparative Efficacy of Racemic Ketamine and Esketamine for Depression

February 15, 2021

Intravenous ketamine appears to be more efficacious than intranasal esketamine for the treatment of depression.

Read More
Argel Aguilar-Valles-Antidepressant Actions of Ketamine Engage Cell-Specific Translation via eIF4E

Antidepressant Actions of Ketamine Engage Cell-Specific Translation via eIF4E

December 16, 2020

Sub-anaesthetic doses of ketamine, a noncompetitive N-methyl-d-aspartate receptor antagonist provide rapid and long-lasting antidepressant effects in these patients, but the molecular mechanism of these effects remains unclear.

Read More
drinking1-Ketamine Can Reduce Harmful Drinking by "Rewriting" Your Memories

Ketamine Can Reduce Harmful Drinking by “Rewriting” Your Memories

June 11, 2020

Maladaptive reward memories (MRMs) are involved in the development and maintenance of acquired overconsumption disorders, such as harmful alcohol and drug use. Here we demonstrate that the N-methyl D-aspartate (NMDA) antagonist ketamine is able to disrupt MRMs in hazardous drinkers when administered immediately after their retrieval.

Read More
Scroll to Top